Contact
Please use this form to send email to PR contact of this press release:
V ClinBio Acquires 49.98% Stake in Cellix to Advance Synergix, a Transformative Pro-drug Technology Platform
TO:
Please use this form to send email to PR contact of this press release:
V ClinBio Acquires 49.98% Stake in Cellix to Advance Synergix, a Transformative Pro-drug Technology Platform
TO: